MBrace Presents ADC Program Poster At 2024 ASCO Annual Meeting
31 May 2024 //
BUSINESSWIRE
MBrace Therapeutics Appoints Steve Alley as Chief Scientific Officer
05 Mar 2024 //
BUSINESSWIRE
MBrace Announces Initiation of Patient Dosing in Ph 1 Trial Evaluating MBRC-101
19 Dec 2023 //
BUSINESSWIRE
MBrace Presents Data Demonstrating Potential of Antibody Drug Conjugate
07 Dec 2023 //
BUSINESSWIRE